First, as applies to osteoprotegerin [52] and retinol binding protein 4 (RBP4) [38], which is an adipokine that enhances atherogenesis, adiponectin is a promising cardiovascular risk biomarker that could improve cardiovascular risk stratification in RA [4–6]. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.